Prevention of chemotherapy-induced neutropenia by special honey intake - PubMed (original) (raw)

Clinical Trial

Prevention of chemotherapy-induced neutropenia by special honey intake

Jamal Zidan et al. Med Oncol. 2006.

Abstract

Febrile neutropenia is a serious side effect of chemotherapy. Colony-stimulating factors (CSFs) are used for primary and secondary treatment in patients with grade 4 neutropenia. The use of CSFs is expensive and accompanied by side effects. In the current study, Life-Mel Honey (LMH) was administered to prevent neutropenia and to reduce the need for CSFs in patients treated with chemotherapy. Thirty cancer patients receiving chemotherapy for primary or metastatic disease were included. All patients had grade 4 neutropenia and were treated with CSFs. The patients repeated the same chemotherapy schedule, with the addition of LMH for 5 d. Blood count was performed weekly. There was no recurrence of neutropenia after LMH intake and no need for treatment with CSFs in 12 (40%) of patients. Eighteen (60%) patients with LMH developed neutropenia grade 4 and were treated with CSFs (p=0.007). Hemoglobin levels remained >11 g/dL during LMH intake in 19 (64%) patients. Only three (10%) patients had thrombocytopenia. Eight (32%) patients reported improvement in quality of life. The use of LMH in patients who are at high risk of developing neutropenia as a result of chemotherapy decreases the risk of pancytopenia and the need for CSFs. LMH is inexpensive, has no side effects, and is easy to administer.

PubMed Disclaimer

Similar articles

• The colony-stimulating factors: use to prevent and treat neutropenia and its complications.
  Komrokji RS, Lyman GH. Komrokji RS, et al. Expert Opin Biol Ther. 2004 Dec;4(12):1897-910. doi: 10.1517/14712598.4.12.1897. Expert Opin Biol Ther. 2004. PMID: 15571452 Review.
• Role of colony stimulating factors (CSFs) in solid tumours: results of an expert panel.
  Gridelli C, Aapro MS, Barni S, Beretta GD, Colucci G, Daniele B, Del Mastro L, Di Maio M, De Petris L, Perrone F, Thatcher N, De Marinis F. Gridelli C, et al. Crit Rev Oncol Hematol. 2007 Jul;63(1):53-64. doi: 10.1016/j.critrevonc.2007.01.008. Epub 2007 Mar 26. Crit Rev Oncol Hematol. 2007. PMID: 17368037 Review.
• The importance of prophylactic management of chemotherapy-induced neutropenia.
  Repetto L, Accettura C. Repetto L, et al. Anticancer Drugs. 2003 Oct;14(9):725-30. doi: 10.1097/00001813-200310000-00006. Anticancer Drugs. 2003. PMID: 14551505 Review.
• Balancing the benefits and costs of colony-stimulating factors: a current perspective.
  Lyman GH. Lyman GH. Semin Oncol. 2003 Aug;30(4 Suppl 13):10-7. doi: 10.1016/s0093-7754(03)00312-9. Semin Oncol. 2003. PMID: 14508715 Review.

Cited by

• Honey as a Potential Natural Antioxidant Medicine: An Insight into Its Molecular Mechanisms of Action.
  Ahmed S, Sulaiman SA, Baig AA, Ibrahim M, Liaqat S, Fatima S, Jabeen S, Shamim N, Othman NH. Ahmed S, et al. Oxid Med Cell Longev. 2018 Jan 18;2018:8367846. doi: 10.1155/2018/8367846. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 29492183 Free PMC article. Review.
• Effect of Processed Honey and Royal Jelly on Cancer-Related Fatigue: A Double-Blind Randomized Clinical Trial.
  Mofid B, Rezaeizadeh H, Termos A, Rakhsha A, Mafi AR, Taheripanah T, Ardakani MM, Taghavi SM, Moravveji SA, Kashi AS. Mofid B, et al. Electron Physician. 2016 Jun 25;8(6):2475-82. doi: 10.19082/2475. eCollection 2016 Jun. Electron Physician. 2016. PMID: 27504161 Free PMC article.
• A Comprehensive Review of the Effect of Honey on Human Health.
  Palma-Morales M, Huertas JR, Rodríguez-Pérez C. Palma-Morales M, et al. Nutrients. 2023 Jul 6;15(13):3056. doi: 10.3390/nu15133056. Nutrients. 2023. PMID: 37447382 Free PMC article. Review.
• Effects of Dietary Honey andArdehCombination on Chemotherapy- Induced Gastrointestinal and Infectious Complications in Patients with Acute Myeloid Leukemia: A Double-Blind Randomized Clinical Trial.
  Ebrahimi M, Allahyari A, Ebrahimi M, Hesam H, Hosseini G, Karimi M, Rezaiean A, Kazemi MR. Ebrahimi M, et al. Iran J Pharm Res. 2016 Spring;15(2):661-8. Iran J Pharm Res. 2016. PMID: 27642340 Free PMC article.
• A Simon's two-stage design trial evaluating the potential role of a kind of honey in preventing chemotherapy-hematopoietic toxicities.
  Sponghini AP, Rondonotti D, Platini F, Cena T, Ferrante D, Stratica F, Gatti A, Magnani C, Gennari A. Sponghini AP, et al. J Tradit Complement Med. 2021 May 5;11(5):466-469. doi: 10.1016/j.jtcme.2021.04.005. eCollection 2021 Sep. J Tradit Complement Med. 2021. PMID: 34522641 Free PMC article.

References

1. 1. Clin Infect Dis. 2002 Mar 15;34(6):730-51 - PubMed
2. 1. J Clin Oncol. 2000 Oct 15;18(20):3558-85 - PubMed
3. 1. Ann Hematol. 1996 Jan;72(1):1-9 - PubMed
4. 1. J Clin Oncol. 1998 Sep;16(9):3179-90 - PubMed
5. 1. J Clin Oncol. 1996 Feb;14(2):636-43 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Springer